APO RESEARCH · REPORT
Fosfomycin Trometamol
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Product & engineering
Understand the product.
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
Selected research
Industry Research
Fosfomycin Trometamol Industry Research Report 2026
Market perspective
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
Global Fosfomycin Trometamol key players include Zambon, Northesat Pharm, Hunan Huana Pharmaceuticals, etc. Global top three manufacturers hold a share over 60%.
Read the full market overview
China is the largest market, with a share over 60%, followed by Europe, with a share over 30 percent.
In terms of product, Fosfomycin Tromethamine Granules is the largest segment, with a share over 55%. And in terms of application, the largest application is Common Urinary Tract Infection, followed by Postoperative Urinary Tract Infection, Preoperative Prevention of Urinary Tract Infection, etc.
Report Scope
This report quantifies the global Fosfomycin Trometamol market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Fosfomycin Trometamol.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fosfomycin Trometamol Market by Company
Zambon
Northesat Pharm
Hunan Huana Pharmaceuticals
Xunda Pharma
FarmaSino Pharmaceutical
Guilin Hwasun
Fosfomycin Trometamol Segment by Type
Fosfomycin Tromethamine Granules
Fosfomycin Tromethamine Powder
Fosfomycin Trometamol Segment by Application
Common Urinary Tract Infection
Postoperative Urinary Tract Infection
Preoperative Prevention of Urinary Tract Infection
Others
Fosfomycin Trometamol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosfomycin Trometamol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fosfomycin Trometamol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosfomycin Trometamol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fosfomycin Trometamol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fosfomycin Trometamol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fosfomycin Trometamol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fosfomycin Tromethamine Granules
- Fosfomycin Tromethamine Powder
Applications
- Common Urinary Tract Infection
- Postoperative Urinary Tract Infection
- Preoperative Prevention of Urinary Tract Infection
- Others
Companies covered
- Zambon
- Northesat Pharm
- Hunan Huana Pharmaceuticals
- Xunda Pharma
- FarmaSino Pharmaceutical
- Guilin Hwasun
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Fosfomycin Trometamol by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Fosfomycin Tromethamine Granules
- 2.2.3 Fosfomycin Tromethamine Powder
- 2.3 Fosfomycin Trometamol by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Common Urinary Tract Infection
- 2.3.3 Postoperative Urinary Tract Infection
- 2.3.4 Preoperative Prevention of Urinary Tract Infection
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Fosfomycin Trometamol Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Fosfomycin Trometamol Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Fosfomycin Trometamol Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Fosfomycin Trometamol Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fosfomycin Trometamol Production by Manufacturers (2021-2026)
- 3.2 Global Fosfomycin Trometamol Production Value by Manufacturers (2021-2026)
- 3.3 Global Fosfomycin Trometamol Average Price by Manufacturers (2021-2026)
- 3.4 Global Fosfomycin Trometamol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fosfomycin Trometamol Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Fosfomycin Trometamol Manufacturers, Product Type & Application
- 3.7 Global Fosfomycin Trometamol Manufacturers Established Date
- 3.8 Global Fosfomycin Trometamol Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zambon
- 4.1.1 Zambon Fosfomycin Trometamol Company Information
- 4.1.2 Zambon Fosfomycin Trometamol Business Overview
- 4.1.3 Zambon Fosfomycin Trometamol Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Zambon Product Portfolio
- 4.1.5 Zambon Recent Developments
- 4.2 Northesat Pharm
- 4.2.1 Northesat Pharm Fosfomycin Trometamol Company Information
- 4.2.2 Northesat Pharm Fosfomycin Trometamol Business Overview
- 4.2.3 Northesat Pharm Fosfomycin Trometamol Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Northesat Pharm Product Portfolio
- 4.2.5 Northesat Pharm Recent Developments
- 4.3 Hunan Huana Pharmaceuticals
- 4.3.1 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Company Information
- 4.3.2 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Business Overview
- 4.3.3 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Hunan Huana Pharmaceuticals Product Portfolio
- 4.3.5 Hunan Huana Pharmaceuticals Recent Developments
- 4.4 Xunda Pharma
- 4.4.1 Xunda Pharma Fosfomycin Trometamol Company Information
- 4.4.2 Xunda Pharma Fosfomycin Trometamol Business Overview
- 4.4.3 Xunda Pharma Fosfomycin Trometamol Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Xunda Pharma Product Portfolio
- 4.4.5 Xunda Pharma Recent Developments
- 4.5 FarmaSino Pharmaceutical
- 4.5.1 FarmaSino Pharmaceutical Fosfomycin Trometamol Company Information
- 4.5.2 FarmaSino Pharmaceutical Fosfomycin Trometamol Business Overview
- 4.5.3 FarmaSino Pharmaceutical Fosfomycin Trometamol Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 FarmaSino Pharmaceutical Product Portfolio
- 4.5.5 FarmaSino Pharmaceutical Recent Developments
- 4.6 Guilin Hwasun
- 4.6.1 Guilin Hwasun Fosfomycin Trometamol Company Information
- 4.6.2 Guilin Hwasun Fosfomycin Trometamol Business Overview
- 4.6.3 Guilin Hwasun Fosfomycin Trometamol Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Guilin Hwasun Product Portfolio
- 4.6.5 Guilin Hwasun Recent Developments
5 Global Fosfomycin Trometamol Production by Region
- 5.1 Global Fosfomycin Trometamol Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fosfomycin Trometamol Production by Region: 2021-2032
- 5.2.1 Global Fosfomycin Trometamol Production by Region: 2021-2026
- 5.2.2 Global Fosfomycin Trometamol Production Forecast by Region (2027-2032)
- 5.3 Global Fosfomycin Trometamol Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Fosfomycin Trometamol Production Value by Region: 2021-2032
- 5.4.1 Global Fosfomycin Trometamol Production Value by Region: 2021-2026
- 5.4.2 Global Fosfomycin Trometamol Production Value Forecast by Region (2027-2032)
- 5.5 Global Fosfomycin Trometamol Market Price Analysis by Region (2021-2026)
- 5.6 Global Fosfomycin Trometamol Production and Value, YOY Growth
- 5.6.1 North America Fosfomycin Trometamol Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Fosfomycin Trometamol Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Fosfomycin Trometamol Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Fosfomycin Trometamol Production Value Estimates and Forecasts (2021-2032)
6 Global Fosfomycin Trometamol Consumption by Region
- 6.1 Global Fosfomycin Trometamol Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Fosfomycin Trometamol Consumption by Region (2021-2032)
- 6.2.1 Global Fosfomycin Trometamol Consumption by Region: 2021-2026
- 6.2.2 Global Fosfomycin Trometamol Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Fosfomycin Trometamol Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Fosfomycin Trometamol Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Fosfomycin Trometamol Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Fosfomycin Trometamol Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Fosfomycin Trometamol Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Fosfomycin Trometamol Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Fosfomycin Trometamol Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Fosfomycin Trometamol Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Fosfomycin Trometamol Production by Type (2021-2032)
- 7.1.1 Global Fosfomycin Trometamol Production by Type (2021-2032) & (MT)
- 7.1.2 Global Fosfomycin Trometamol Production Market Share by Type (2021-2032)
- 7.2 Global Fosfomycin Trometamol Production Value by Type (2021-2032)
- 7.2.1 Global Fosfomycin Trometamol Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Fosfomycin Trometamol Production Value Market Share by Type (2021-2032)
- 7.3 Global Fosfomycin Trometamol Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Fosfomycin Trometamol Production by Application (2021-2032)
- 8.1.1 Global Fosfomycin Trometamol Production by Application (2021-2032) & (MT)
- 8.1.2 Global Fosfomycin Trometamol Production Market Share by Application (2021-2032)
- 8.2 Global Fosfomycin Trometamol Production Value by Application (2021-2032)
- 8.2.1 Global Fosfomycin Trometamol Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Fosfomycin Trometamol Production Value Market Share by Application (2021-2032)
- 8.3 Global Fosfomycin Trometamol Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Fosfomycin Trometamol Value Chain Analysis
- 9.1.1 Fosfomycin Trometamol Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Fosfomycin Trometamol Production Mode & Process
- 9.2 Fosfomycin Trometamol Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Fosfomycin Trometamol Distributors
- 9.2.3 Fosfomycin Trometamol Customers
10 Global Fosfomycin Trometamol Analyzing Market Dynamics
- 10.1 Fosfomycin Trometamol Industry Trends
- 10.2 Fosfomycin Trometamol Industry Drivers
- 10.3 Fosfomycin Trometamol Industry Opportunities and Challenges
- 10.4 Fosfomycin Trometamol Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst